Apply for Funding
We are committed to supporting the highest standard of research in pursuit of our mission. Currently, the Myrovlytis Trust provides grants for research into our priority areas of Birt-Hogg-Dubé Syndrome, related kidney disorders and osteosarcoma.
The Myrovlytis Trust encourages applications from innovative laboratories worldwide.
2023 Grant Funding Call
Our 2023 grant funding call is now closed and we are no longer accepting Project Grants, PhD Studentships and Small/ Pilot Studies or Public Engagement Grants. Our travel grant applications are now also closed.
We still welcome initial pre-proposals before submission of the full grant application form. Please download and complete our pre-proposal form (download the form here) and email the pre-proposal to email@example.com. You can also email us with any queries regarding the grant application process.
Read our full application guidelines.
Applications open: 1st February 2023
Application Submission Deadline: 28th April 2023, 17:00 GMT
Applicants notified of outcome: 25th September 2023
Notes for applicants:
The Myrovlytis Trust follows the Association of Medical Research Charities’ (AMRC) guidance on peer review and adheres to their five principles of peer review: accountability, balance, independence, rotation and impartiality.
Our application evaluation procedure can be found here.
Read our conflicts of interest policy here.
All publications resulting from studies funded by the Myrovlytis Trust should acknowledge the funding source.
Small/ Pilot Studies
Up to £20,000 funding to initiate a one-year study with clear milestones related to our aims.
3.5 years funding for a PhD student, including stipend, university fees and consumables. These are generally capped at £95,000 (according to standard costings in the UK), but we are of course happy to discuss variations across countries.
Funding of up to £300,000 is available for project grants of 3 years.
Public Engagement Grants
Grants of up to £5000 are available for projects involving patients and/or the public in order to advance knowledge, provide advocacy and raise awareness of rare diseases and new technologies. We are not currently accepting public engagement grants.
Travel grants are available to support attendance at a conference or international collaborative research in the Trust’s priority research areas. The maximum individual award is £1000. We are not currently accepting travel grants.
Use of Animals in Medical Research
The Myrovlytis Trust fully endorses the Association of Medical Research Charities’ (AMRC) position on the use of animals in research. We support the principles of the 3Rs of animals in research: Replacement, Refinement and Reduction. All researchers seeking funding from the Myrovlytis Trust must demonstrate consideration to the 3Rs and provide clear evidence of implementation of this strategy in their application. All members of our advisory board, grants panel and reviewers of grants are made aware of our commitment to this policy.
If your research application involves the use of animals in research, please complete our Use of Animals in Research Form and attach this to your application.
Supporting Universities in Research
The Myrovlytis Trust endorses the Association of Medical Research Charities’ (AMRC) position statement on supporting research in universities. The Myrovlytis Trust does not cover indirect costs of research grant such as IT infrastructure, estates and administration overheads. Instead, researchers who hold grants from the Myrovlytis Trust are eligible to apply to the Charity Research Support Fund (CRSF). The CSRF is a partnership between charities, universities and the government to enable universities in receipt of charity grants to achieve a higher level of full economic costs and promoting sustainability of research.
Connect with us…
Back to top